FindTrial
Sign In

Aberrant DNA methylation profiles of circulation cell-free DNA as a biomarker applied in clinical practice of breast cancer

Aberrant DNA methylation profiles of circulation cell-free DNA as a biomarker applied in clinical practice of breast cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-DCC-12001917
Enrollment
Unknown
Registered
2012-02-01
Start date
2012-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Interventions

Gold Standard:
Index test:

Sponsors

Nanjing Maternity and Child Health Hospital of Nanjing Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 75 Years

Inclusion criteria

Inclusion criteria: New cases of breast cancer with pathological diagosis

Exclusion criteria

Exclusion criteria: 1. cases of breast cancer recurrence/metastasis 2. cases combined with other malignant diseases

Design outcomes

Primary

MeasureTime frame
DNA methylation profiles in peripheral blood;—

Countries

China

Contacts

Public ContactCheng Lu
lucheng66@126.com+86 025 52226127

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026